IMPAC Medical Systems and Synovate Healthcare
IMPAC Medical Systems, Inc., part of the Elekta Group and a leading provider of information technology solutions for oncology care, and Synovate Healthcare, a specialist division of global research firm Synovate, will align to supplement Synovate’s global cancer therapy audit with longitudinal oncology data that will enhance Synovate’s current offerings and allow creation of new services and insight into the market. In this multi-year agreement, Synovate will license aggregated and de-identified data collected from users of IMPAC’s leading oncology EMR and cancer registry systems. This will enable Synovate to provide timely and accurate, de-identified information to pharmaceutical and biotech companies in an effort to further oncology research.
“This alliance will enable us to expand our current data collection methods from paper to electronic – exponentially impacting the speed of oncology data collected and allowing us to better analyze, understand, and extrapolate trends and outcomes in oncology care,” stated Michael Spedding, CEO of Synovate Healthcare.
“IMPAC’s goal from the beginning has been to promote healthcare technology to deliver practical solutions that will improve overall communication, process efficiency, and the quality of patient care,” added Joseph K. Jachinowski, president and CEO of IMPAC Medical Systems. “Sharing the longitudinal data collected from the National Oncology Database™ (NODB) solidifies our goals and achievements over our 15 year history. This is a significant development in market research that ultimately will be demonstrated with improved patient care.”
This agreement represents a considerable step forward in market research through the quantity and quality of longitudinal data to be shared and analyzed. Synovate will gain access to the electronic data of more than 2.3 million cases resident in the IMPAC NODB and augmented by IMPAC software products and services which span the spectrum of cancer care.
About IMPAC Medical Systems
IMPAC Medical Systems, Inc., a wholly owned subsidiary of Elekta AB, is a leading provider of oncology IT solutions that streamline both clinical and business operations to help improve the process of delivering quality patient care. With systems designed for anatomic pathology, medical oncology, radiation oncology, imaging, clinical laboratory, and cancer registry, IMPAC supports the entire team of healthcare professionals who contribute to the care of the cancer patient. Supporting more than 2500 installations worldwide, IMPAC provides practical solutions that deliver better overall communication, process efficiency and quality patient care. For more information about IMPAC’s products or services, please call 888-GO-IMPAC or visit www.impac.com .
The Elekta Group is a world-leading supplier of advanced and innovative radiation oncology and neurosurgery solutions and services for precise treatment of cancer and brain disorders.
About Synovate Healthcare
Synovate, the market research arm of Aegis Group plc, generates consumer insights that drive competitive market solutions. The network provides clients cohesive global support and a comprehensive suite of research solutions. Synovate employs over 4000 staff in 44 countries. More information can be found at www.synovate.com .
